Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study

Fig. 3

Endoscopic severity (MES) both at entry and after GMA treatment showed significant positive relationship with the levels of faecal calprotectin. At entry, the median faecal calprotectin level was significantly higher in patients with MES 3 than in those with MES 2 (P < 0.001 by the Mann-Whitney U test). After GMA treatment, the median faecal calprotectin level was significantly higher in patients with higher MES (P < 0.001 by the Kruskal-Wallis test)

Back to article page